[Federal Register Volume 66, Number 7 (Wednesday, January 10, 2001)]
[Notices]
[Page 2005]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-755]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the code of Federal 
Regulations (CFR), this is notice that on October 13, 2000, Orpharm, 
Inc., 4815 Dacoma Street, Houston, Texas 77092, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
 Methylphenidate (1724)....................  II
 Methadone (9250)..........................  II
 Methadone-intermediate (9254).............  II
 Levo-alphacetylmethadol (9648)............  II
------------------------------------------------------------------------

    The firm plans to manufacture methadone and methadone-intermediate 
for production of LAAM, and to manufacture methylphenidate for a 
customer.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy assistant Administrator, Office of Diversion Control, 
Drug enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than March 12, 2001.

    Dated: December 21, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-755 Filed 1-9-01; 8:45 am]
BILLING CODE 4410-09-M